Daqo New Vitality (DQ) closed the newest buying and
Daqo New Vitality (DQ) closed the newest buying and selling day at $75.19, shifting -0.41% from the earlier buying and selling session. This transformation lagged the S&P 500’s each day acquire of 1.18%. On the similar time, the Dow added 0.52%, and the tech-heavy Nasdaq gained 1.76%.
Previous to right now’s buying and selling, shares of the photo voltaic panel elements maker had misplaced 20.11% over the previous month. This has lagged the Fundamental Supplies sector’s acquire of three.87% and the S&P 500’s acquire of 4.55% in that point.
Wall Avenue can be on the lookout for positivity from DQ because it approaches its subsequent earnings report date. In that report, analysts anticipate DQ to submit earnings of $1.15 per share. This is able to mark year-over-year progress of 150%. Our most up-to-date consensus estimate is asking for quarterly income of $242.eight million, up 43.81% from the year-ago interval.
DQ’s full-year Zacks Consensus Estimates are calling for earnings of $5.23 per share and income of $1.1 billion. These outcomes would characterize year-over-year modifications of +204.07% and +62.29%, respectively.
Any current modifications to analyst estimates for DQ also needs to be famous by traders. These current revisions are inclined to mirror the evolving nature of short-term enterprise traits. As such, optimistic estimate revisions mirror analyst optimism in regards to the firm’s enterprise and profitability.
Analysis signifies that these estimate revisions are straight correlated with near-term share value momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate modifications into consideration and delivers a transparent, actionable score mannequin.
Starting from #1 (Sturdy Purchase) to #5 (Sturdy Promote), the Zacks Rank system has a confirmed, outside-audited monitor report of outperformance, with #1 shares returning a mean of +25% yearly since 1988. Over the previous month, the Zacks Consensus EPS estimate has moved 30.1% greater. DQ is at present sporting a Zacks Rank of #1 (Sturdy Purchase).
Taking a look at its valuation, DQ is holding a Ahead P/E ratio of 14.44. This represents a reduction in comparison with its business’s common Ahead P/E of 17.56.
The Chemical – Specialty business is a part of the Fundamental Supplies sector. This business at present has a Zacks Trade Rank of 109, which places it within the high 43% of all 250+ industries.
The Zacks Trade Rank consists of is listed so as from greatest to worst by way of the common Zacks Rank of the person firms inside every of those sectors. Our analysis reveals that the highest 50% rated industries outperform the underside half by an element of two to 1.
You’ll want to observe all of those stock-moving metrics, and plenty of extra, on Zacks.com.
Need the newest suggestions from Zacks Funding Analysis? Right now, you’ll be able to obtain 7 Greatest Shares for the Subsequent 30 Days. Click on to get this free report
DAQO New Vitality Corp. (DQ): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.